Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The 2017 Oxford University iGEM team have just returned from the competition in Boston with not only a Gold medal but also the extremely competitive award for Best Diagnostics Project in the Undergraduate category. In addition they were nominated for five further awards for best presentation, wiki, model, integrated human practices and best applied design.

The iGEM competition challenges interdisciplinary teams of students to spend the summer working on applying Synthetic Biology to address real world issues. The undergraduates drive the project from beginning to end. This year’s team of 6 female and 6 male students, from Biochemistry, Engineering, Biology and Medicine, set out to develop a cheap and reliable diagnostic for Chagas disease. Chagas disease is a parasitic infection affecting millions of poor people in South America. If is diagnosed early it can be treated, but can be fatal if treatment is delayed.

The team interacted with stakeholders both in the UK and in the affected regions to guide their project. They used mathematical modelling to predict the behaviour of, and optimise, the genetic circuitry for their device before producing and testing various components in the laboratory. They also carried out iterations of designs and costings for their device and considered the potential benefits and issues around its use in the field.

Finally, the project culminated in Boston where they competed with more than 300 other teams from across the world, presenting their design and results to more than 3000 people at the Jamboree.

Find out more about their project (external link)

Similar stories

Study reveals ‘stop-eating’ response to DNA damage

A new study from the MRC Weatherall Institute of Molecular Medicine sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.

Fiona Powrie appointed new Deputy Chair of Wellcome’s Board of Governors

Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.

World’s first cancer prevention trial to test diabetes drug in patients with high-risk genetic condition

Oxford researchers will lead a £2m national cancer prevention trial to assess the benefit a diabetes drug has in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.

One high altitude explorer acknowledges another

NASA Astronaut and Physiologist Dr Jessica Meir unveils The Physiological Society blue plaque in honour of fellow pioneering Physiologist and Scientific Explorer Mabel FitzGerald.

Oxford-led research maps milestone stage of human development for the first time

Scientists have shed light on an important stage of early embryonic development that has never been fully mapped out in humans before.